{
"id":"mk19_bb_hm_s7",
"subspecialtyId":"hm",
"title":"Acute Lymphoblastic Leukemia",
"jsonContent":{
"type":"section",
"id":"mk19_bb_hm_s7",
"title":{
"__html":"Acute Lymphoblastic Leukemia"
},
"titleNode":{
"type":"section-title",
"hlId":"17671c",
"children":[
"Acute Lymphoblastic Leukemia"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_hm_s7_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"1d7097",
"children":[
{
"type":"abbreviation",
"title":"acute lymphoblastic leukemia",
"children":[
"ALL"
]
},
" is an extremely aggressive disease of precursor T or B cells. The usual presenting clinical features include rapidly rising blast cells in the blood and bone marrow, bulky lymphadenopathy (especially in the mediastinum), a younger age at onset, and cytopenia secondary to bone marrow involvement. Patients with ALL may have ",
{
"type":"abbreviation",
"title":"central nervous system",
"children":[
"CNS"
]
},
" involvement."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s7_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"e5c1ab",
"children":[
"Induction therapy involves intensive combination chemotherapy often followed by allogeneic ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"hematopoietic stem cell transplantation",
"children":[
"HSCT"
]
},
"."
]
}
]
},
{
"type":"p",
"hlId":"2e2a01",
"children":[
"CNS prophylaxis (intrathecal chemotherapy with or without radiation) is also indicated."
]
},
{
"type":"p",
"hlId":"968498",
"children":[
"Patients who are positive for the Philadelphia chromosome [t(9;22)] can be treated with the tyrosine kinase inhibitor imatinib or dasatinib in addition to chemotherapy and allogeneic HSCT."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_hm_s7_3",
"title":{
"__html":"Follow-up"
},
"titleNode":{
"type":"section-title",
"hlId":"b9c20d",
"children":[
"Follow-up"
]
},
"children":[
{
"type":"p",
"hlId":"43bdb8",
"children":[
"Adult survivors of childhood leukemia are at high risk of secondary cancer, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"cardiovascular disease",
"children":[
"CVD"
]
},
","
]
},
" and metabolic syndrome. Screening for dyslipidemia, diabetes, and hypertension is recommended. Echocardiography should be performed periodically if anthracycline exposure was high."
]
}
]
}
]
},
"tablesContent":{
}
}